表皮成長因子（EGF）の世界及び中国市場

• 英文タイトル：Global and China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Insights, Forecast to 2027

• レポートコード：QY2108PAL8818
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、132ページ
• 納品方法：Eメール（納期：1日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の当調査資料ではグローバルにおける表皮成長因子（EGF）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、表皮成長因子（EGF）の種類別市場規模（液体、粉末）、用途別市場規模（EGFクリーム、EGFローション、EGFマスク、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界の表皮成長因子（EGF）市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界における表皮成長因子（EGF）の種類別市場規模（2016年-2027年）：液体、粉末
・世界における表皮成長因子（EGF）の用途別市場規模（2016年-2027年）：EGFクリーム、EGFローション、EGFマスク、その他
・表皮成長因子（EGF）の中国市場分析
- 表皮成長因子（EGF）の中国市場規模（2016年-2027年）
- 中国における表皮成長因子（EGF）の主要プレイヤー別市場シェア
- 中国における表皮成長因子（EGF）の種類別市場規模：液体、粉末
- 中国における表皮成長因子（EGF）の用途別市場規模：EGFクリーム、EGFローション、EGFマスク、その他
・表皮成長因子（EGF）の北米市場（2016年-2027年）
・表皮成長因子（EGF）のヨーロッパ市場（2016年-2027年）
・表皮成長因子（EGF）のアジア太平洋市場（2016年-2027年）
・表皮成長因子（EGF）の中南米市場（2016年-2027年）
・表皮成長因子（EGF）の中東・アフリカ市場（2016年-2027年）
・主要プレイヤーの情報：Pavay、Radiant、BIO-FDandC、LipoTrue、BIOEFFECT
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.

EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that’s why most skin care maker use EGF to care our skin.

And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.
Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) key players include Pavay, Radiant Inc., BIO-FDandC Co.,Ltd, LipoTrue, S.L, BIOEFFECT, etc. Global top five players hold a share about 85%.
China is the largest market, with a share about 55%, followed by North America and Europe, having a total share about 25 percent.
In terms of product, Liquid is the largest segment, with a share about 75%. And in terms of application, the largest application is EGF Cream, followed by EGF Lotion, EGF Mask, etc.

Market Analysis and Insights: Global and China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market
This report focuses on global and China Epidermal Growth Factor (EGF) (CAS 62253-63-8) market.
In 2020, the global Epidermal Growth Factor (EGF) (CAS 62253-63-8) market size was US$ 128.3 million and it is expected to reach US$ 189.1 million by the end of 2027, with a CAGR of 5.7% during 2021-2027. In China the Epidermal Growth Factor (EGF) (CAS 62253-63-8) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Scope and Market Size
Epidermal Growth Factor (EGF) (CAS 62253-63-8) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Epidermal Growth Factor (EGF) (CAS 62253-63-8) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Epidermal Growth Factor (EGF) (CAS 62253-63-8) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Liquid
Powder

Segment by Application
EGF Cream
EGF Lotion
EGF Mask
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Pavay
Radiant
BIO-FDandC
LipoTrue
BIOEFFECT

レポート目次

1 Study Coverage
1.1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Introduction
1.2 Market by Type
1.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size Growth Rate by Type
1.2.2 Liquid
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size Growth Rate by Application
1.3.2 EGF Cream
1.3.3 EGF Lotion
1.3.4 EGF Mask
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size, Estimates and Forecasts
2.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue 2016-2027
2.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales 2016-2027
2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Historical Market Size by Region (2016-2021)
2.3.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Region (2022-2027)
2.4.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Region (2022-2027)

3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Competitor Landscape by Players
3.1 Global Top Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturers by Sales
3.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Manufacturer (2016-2021)
3.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturers by Revenue
3.2.1 Key Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Manufacturers (2016-2021)
3.2.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue in 2020
3.2.6 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price by Manufacturers
3.4 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturing Base Distribution, Product Types
3.4.1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Type
3.4.3 Date of International Manufacturers Enter into Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size by Type (2016-2021)
4.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021)
4.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Type (2016-2021)
4.1.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size Forecast by Type (2022-2027)
4.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Type (2022-2027)
4.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Type (2022-2027)
4.2.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size by Application (2016-2021)
5.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021)
5.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Application (2016-2021)
5.1.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price by Application (2016-2021)
5.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size Forecast by Application (2022-2027)
5.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Application (2022-2027)
5.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Application (2022-2027)
5.2.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size YoY Growth 2016-2027
6.1.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales YoY Growth 2016-2027
6.1.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue YoY Growth 2016-2027
6.1.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Share in Global Market 2016-2027
6.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size by Players (International and Local Players)
6.2.1 China Top Epidermal Growth Factor (EGF) (CAS 62253-63-8) Players by Sales (2016-2021)
6.2.2 China Top Epidermal Growth Factor (EGF) (CAS 62253-63-8) Players by Revenue (2016-2021)
6.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Historic Market Review by Type (2016-2021)
6.3.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
6.3.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Type (2016-2021)
6.3.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price by Type (2016-2021)
6.4 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Type (2022-2027)
6.4.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Type (2022-2027)
6.4.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price Forecast by Type (2022-2027)
6.5 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Historic Market Review by Application (2016-2021)
6.5.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
6.5.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Application (2016-2021)
6.5.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price by Application (2016-2021)
6.6 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Application (2022-2027)
6.6.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Application (2022-2027)
6.6.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price Forecast by Application (2022-2027)

7 North America
7.1 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size YoY Growth 2016-2027
7.2 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures by Country
7.2.1 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021)
7.2.2 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures by Region
8.2.1 Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Region (2016-2021)
8.2.2 Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size YoY Growth 2016-2027
9.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures by Country
9.2.1 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021)
9.2.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size YoY Growth 2016-2027
10.2 Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures by Country
10.2.1 Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021)
10.2.2 Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures by Country
11.2.1 Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Pavay
12.1.1 Pavay Corporation Information
12.1.2 Pavay Description and Business Overview
12.1.3 Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.1.5 Pavay Recent Development
12.2 Radiant
12.2.1 Radiant Corporation Information
12.2.2 Radiant Description and Business Overview
12.2.3 Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.2.5 Radiant Recent Development
12.3 BIO-FDandC
12.3.1 BIO-FDandC Corporation Information
12.3.2 BIO-FDandC Description and Business Overview
12.3.3 BIO-FDandC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 BIO-FDandC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.3.5 BIO-FDandC Recent Development
12.4 LipoTrue
12.4.1 LipoTrue Corporation Information
12.4.2 LipoTrue Description and Business Overview
12.4.3 LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.4.5 LipoTrue Recent Development
12.5 BIOEFFECT
12.5.1 BIOEFFECT Corporation Information
12.5.2 BIOEFFECT Description and Business Overview
12.5.3 BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.5.5 BIOEFFECT Recent Development
12.11 Pavay
12.11.1 Pavay Corporation Information
12.11.2 Pavay Description and Business Overview
12.11.3 Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.11.5 Pavay Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Industry Trends
13.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Drivers
13.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Challenges
13.4 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Liquid
Table 3. Major Manufacturers of Powder
Table 4. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size Growth Rate by Application (2021-2027) & (g)
Table 5. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size by Region (g) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Regions (2016-2021) & (g)
Table 7. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Regions (2016-2021)
Table 8. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Region (2022-2027) & (g)
Table 10. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Manufacturers (2016-2021) (g)
Table 14. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturers by Revenue (US$ Million) in 2020
Table 16. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Manufacturers (2016-2021)
Table 18. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor (EGF) (CAS 62253-63-8) as of 2020)
Table 20. Key Manufacturers Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (2016-2021) (USD/g)
Table 21. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Type
Table 23. Date of International Manufacturers Enter into Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021) (g)
Table 26. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Type (2016-2021)
Table 27. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Type (2016-2021)
Table 29. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Selling Price (ASP) by Type (2016-2021) & (USD/g)
Table 30. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Type (2022-2027) & (g)
Table 31. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/g)
Table 35. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021) (g)
Table 36. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Application (2016-2021)
Table 37. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Application (2016-2021)
Table 39. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Selling Price (ASP) by Application (2016-2021) & (USD/g)
Table 40. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Application (2022-2027) & (g)
Table 41. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/g)
Table 45. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) of Key Companies (2016-2021)
Table 46. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Company (2016-2021)
Table 47. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) by Company (2016-2021)
Table 48. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Company (2016-2021)
Table 49. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Type (2016-2021)
Table 50. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Type (2016-2021)
Table 51. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Type (2016-2021)
Table 53. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Type (2022-2027)
Table 54. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Type (2022-2027)
Table 55. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Type (2022-2027)
Table 57. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Type (2022-2027)
Table 58. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Application (2016-2021)
Table 59. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Application (2016-2021)
Table 60. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Application (2016-2021)
Table 62. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Application (2022-2027)
Table 63. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Application (2022-2027)
Table 64. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Application (2022-2027)
Table 66. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Application (2022-2027)
Table 67. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021) & (g)
Table 68. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country (2016-2021)
Table 69. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Region (2016-2021) & (g)
Table 72. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Region (2016-2021)
Table 75. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021) & (g)
Table 76. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country (2016-2021)
Table 77. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country (2016-2021)
Table 79. Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021) & (g)
Table 80. Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Country (2016-2021) & (g)
Table 84. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country (2016-2021)
Table 87. Pavay Corporation Information
Table 88. Pavay Description and Business Overview
Table 89. Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 90. Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product
Table 91. Pavay Recent Development
Table 92. Radiant Corporation Information
Table 93. Radiant Description and Business Overview
Table 94. Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 95. Radiant Product
Table 96. Radiant Recent Development
Table 97. BIO-FDandC Corporation Information
Table 98. BIO-FDandC Description and Business Overview
Table 99. BIO-FDandC Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 100. BIO-FDandC Product
Table 101. BIO-FDandC Recent Development
Table 102. LipoTrue Corporation Information
Table 103. LipoTrue Description and Business Overview
Table 104. LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 105. LipoTrue Product
Table 106. LipoTrue Recent Development
Table 107. BIOEFFECT Corporation Information
Table 108. BIOEFFECT Description and Business Overview
Table 109. BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 110. BIOEFFECT Product
Table 111. BIOEFFECT Recent Development
Table 112. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Trends
Table 113. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Drivers
Table 114. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Challenges
Table 115. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Restraints
Table 116. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Customers List
Table 117. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Picture
Figure 2. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020 & 2027
Figure 3. Liquid Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020 & 2027
Figure 6. EGF Cream
Figure 7. EGF Lotion
Figure 8. EGF Mask
Figure 9. Other
Figure 10. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Report Years Considered
Figure 11. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size 2016-2027 (US$ Million)
Figure 13. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales 2016-2027 (g)
Figure 14. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Region (2016-2021)
Figure 16. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Region in 2020
Figure 17. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Region (2016-2021)
Figure 18. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Region in 2020
Figure 19. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue in 2020
Figure 21. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
Figure 23. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020
Figure 24. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Type (2016-2021)
Figure 25. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Type in 2020
Figure 26. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
Figure 27. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020
Figure 28. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Application (2016-2021)
Figure 29. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Application in 2020
Figure 30. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate 2016-2027 (g)
Figure 31. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Epidermal Growth Factor (EGF) (CAS 62253-63-8) Players Market Share by Revenue in Epidermal Growth Factor (EGF) (CAS 62253-63-8) in 2020
Figure 34. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Type (2016-2021)
Figure 35. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Application (2016-2021)
Figure 37. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate 2016-2021 (g)
Figure 39. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country in 2020
Figure 41. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country in 2020
Figure 42. U.S. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 43. U.S. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 45. Canada Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate 2016-2021 (g)
Figure 47. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country in 2020
Figure 49. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country in 2020
Figure 50. Germany Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 51. Germany Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 53. France Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 55. U.K. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 57. Italy Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 59. Russia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate 2016-2021 (g)
Figure 61. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Region in 2020
Figure 63. Asia Pacific Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Region in 2020
Figure 64. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 65. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 67. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 69. South Korea Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 71. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 73. Australia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 75. China Taiwan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 77. Indonesia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 79. Thailand Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 81. Malaysia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate 2016-2021 (g)
Figure 83. Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country in 2020
Figure 85. Latin America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country in 2020
Figure 86. Mexico Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 87. Mexico Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Brazil Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 89. Brazil Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Argentina Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 91. Argentina Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate 2016-2021 (g)
Figure 93. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Country in 2020
Figure 95. Middle East and Africa Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Country in 2020
Figure 96. Turkey Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 97. Turkey Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Saudi Arabia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 99. Saudi Arabia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. UAE Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2021) (g)
Figure 101. UAE Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed

以下、関連資料のご紹介

上皮成長因子（EGF）の世界市場 2020年

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201104189 2020年10月20日 108Pages
本書では、上皮成長因子（EGF）の世界市場を調査対象にし、上皮成長因子（EGF）の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（液体、粉末）、用途別分析（EGFクリーム、EGFローション...

ヒト凝固因子VIIの世界及び中国市場

Global and China Human Coagulation Factor VII Market Insights, Forecast to 2027
QY2108PAL8851 2021年7月 128Pages
QYResearch社発行の当調査資料ではグローバルにおけるヒト凝固因子VIIの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ヒト凝固因子VIIの種類別市場規模（組換え第VIII因子、血漿由来第VIII因子）、用途別市場規模（血友病A、自...

ヒト凝固第VIII因子の世界及び中国市場

Global and China Human Coagulation Factor VIII Market Insights, Forecast to 2027
QY2108PAL8852 2021年7月 149Pages
QYResearch社発行の当調査資料ではグローバルにおけるヒト凝固第VIII因子の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ヒト凝固第VIII因子の種類別市場規模（組換え第VIII因子、血漿由来第VIII因子）、用途別市場規模（血友...

トランスフォーミング増殖因子β1の世界及び中国市場

Global and China Transforming Growth Factor Beta 1 Market Insights, Forecast to 2027
QY2108PAL8947 2021年6月 145Pages
QYResearch社発行の当調査資料ではグローバルにおけるトランスフォーミング増殖因子β1の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、トランスフォーミング増殖因子β1の種類別市場規模（ピルフェニドン、ガルニセルチブ、その他）、用途別...

MRI（磁気共鳴画像システム）の世界及び中国市場

Global and China MRI (Magnetic Resonance Imaging System) Market Insights, Forecast to 2027
QY2108PAL8644 2021年6月 140Pages
QYResearch社発行の当調査資料ではグローバルにおけるMRI（磁気共鳴画像システム）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、MRI（磁気共鳴画像システム）の種類別市場規模（永久磁石、超電導）、用途別市場規模（クリニック、実験...

心電図（CTG）の世界及び中国市場

Global and China Cardiotocograph (CTG) Market Insights, Forecast to 2027
QY2108PAL8416 2021年6月 147Pages
QYResearch社発行の当調査資料ではグローバルにおける心電図（CTG）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、心電図（CTG）の種類別市場規模（従来CTG、インテリジェントCTG）、用途別市場規模（病院、臨床、家庭）も掲載し...

血管閉鎖装置（VCD）の世界及び中国市場

Global and China Vascular Closure Devices (VCDS) Market Insights, Forecast to 2027
QY2108PAL8557 2021年6月 122Pages
QYResearch社発行の当調査資料ではグローバルにおける血管閉鎖装置（VCD）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、血管閉鎖装置（VCD）の種類別市場規模（5F-6F、5F-21F）、用途別市場規模（血管造影手術、介入手順）...

自動体外式除細動器（AED）の世界及び中国市場

Global and China Automated External Defibrillators (AEDs) Market Insights, Forecast to 2027
QY2108PAL8383 2021年6月 153Pages
QYResearch社発行の当調査資料ではグローバルにおける自動体外式除細動器（AED）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、自動体外式除細動器（AED）の種類別市場規模（半自動、全自動）、用途別市場規模（病院、公立病院、家庭、...

ヒアルロン酸（ナトリウム+注射）の世界及び中国市場

Global and China Hyaluronic Acid (Sodium +Injection) Market Insights, Forecast to 2027
QY2108PAL8854 2021年6月 139Pages
QYResearch社発行の当調査資料ではグローバルにおけるヒアルロン酸（ナトリウム+注射）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ヒアルロン酸（ナトリウム+注射）の種類別市場規模（ヒアルロン酸注射、ヒアルロン酸ナトリウム）、用途...

フローイメージング顕微鏡（動的画像分析）の世界及び中国市場

Global and China Flow Imaging Microscopy (Dynamic Image Analysis) Market Insights, Forecast to 2027
QY2108PAL8510 2021年6月 138Pages
QYResearch社発行の当調査資料ではグローバルにおけるフローイメージング顕微鏡（動的画像分析）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、フローイメージング顕微鏡（動的画像分析）の種類別市場規模（ウェット分散、ドライ分散）、用途...

上皮成長因子（EGF）の世界市場 2020年 Market Overview The Epidermal Growth Factor (EGF) (CAS 62253-63-8) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, …
ヒト凝固因子VIIの世界及び中国市場 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
ヒト凝固因子VIIの世界市場 2020年 Market Overview The Human Coagulation Factor VII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
力率改善（PFC）装置の世界市場 2020年 Market Overview The Power Factor Correction Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
線維芽細胞成長因子2の世界市場 2020年 Market Overview The global Fibroblast Growth Factor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibroblast Growth …